| 000 | 01561 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513170443.0 | ||
| 264 | 0 | _c19990716 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0022-3751 | ||
| 024 | 7 |
_a10.1111/j.1469-7793.1999.201aa.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKajimura, M | |
| 245 | 0 | 0 |
_aInhibition of effects of flow on potassium permeability in single perfused frog mesenteric capillaries. _h[electronic resource] |
| 260 |
_bThe Journal of physiology _cApr 1999 |
||
| 300 |
_a201-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCapillaries _xdrug effects |
| 650 | 0 | 4 |
_aCyclic AMP _xphysiology |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDecerebrate State |
| 650 | 0 | 4 |
_aEpoprostenol _xphysiology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 | _aRana pipiens |
| 650 | 0 | 4 | _aRana temporaria |
| 650 | 0 | 4 |
_aSplanchnic Circulation _xdrug effects |
| 650 | 0 | 4 |
_aomega-N-Methylarginine _xpharmacology |
| 700 | 1 | _aMichel, C C | |
| 773 | 0 |
_tThe Journal of physiology _gvol. 516 ( Pt 1) _gp. 201-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1469-7793.1999.201aa.x _zAvailable from publisher's website |
| 999 |
_c10027048 _d10027048 |
||